glp-1 and gip LY3437943, a novel triple glucagon, GIP, receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism How May GIP Enhance the

[12] [1] Liu J, Head E, Kuratsune H, Cotman CW, Ames BN

doi: 10.1111/dmcn.12771 16 MoeschlerJBShevellMCommittee on G

After 12 weeks, the researchers noted the following weight changes in the two groups: [table id=356 /] The following blood work changes were also found in the two groups: [table id=357 /] For the researchers, 12 weeks of carnitine administration in women with polycystic ovary syndrome resulted in reductions in weight, body mass index, weight circumference, and hip circumference, and beneficial effects on blood sugar control though they admit that Further long-term studies with higher doses of carnitine are needed to examine the effect of carnitine supplementation on markers of insulin resistance, lipid profiles and hormonal outcomes in polycystic ovary syndrome patients. * HOMA RI is used as a screening test for glucose intolerance

There's a much more interesting part, and it has to do with mitochondria , one of our favorite subjects here on the PricePlow Blog